Conference Proceedings
Quantifying early gastric cancer in Australia: What is the opportunity for gastric endoscopic submucosal dissection?
Linda S Yang, Andrew CF Taylor, Alexander J Thompson, Paul Desmond, Bronte A Holt
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | WILEY | Published : 2021
DOI: 10.1111/jgh.15552
Abstract
BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is the recommended treatment for early gastric cancer (EGC). However, there are challenges in attaining expertise in ESD in countries where the incidence of gastric cancer and proportion diagnosed at an early stage of disease are relatively low. This study aims to establish the proportion of gastric cancer meeting histological criteria for EGC, which may be suitable for ESD, in a Western population. METHODS: Gastric cancers reported to the Victorian Cancer Registry between January 2011 and December 2016 were analyzed. EGC was defined as tumor confined to mucosa (T1a) or submucosa (T1b). Histology reports were analyzed using Japanese..
View full abstractGrants
Awarded by National Health and Medical Research Council of Australia
Funding Acknowledgements
Acknowledgement made to Ms Vicky Thursfield at the Cancer Council Australia for administrative assistance and arrangements for data collection. LY received Australian Postgraduate Award through the University of Melbourne. AJT received funding from the National Health and Medical Research Council of Australia (MRFF Practitioner Fellowship 1142976). BAH received funding from the National Health and Medical Research Council of Australia (Early Career Fellowship).